Prophylactic platelet transfusion in acute leukaemia
Murphy, W.G.
Lancet 339(8785): 120; Author Reply 120-1
1992
ISSN/ISBN: 0140-6736 PMID: 1345837 Document Number: 390029
Document emailed within 1 workday
Related Documents
Finazzi, G. 1998: Prophylactic platelet transfusion in acute leukemia: which threshold should be used Haematologica 83(11): 961-962Stopera, S.A.; Ray, M. 1989: Expression and distribution of aphidicolin-induced fragile sites in chronic myeloid leukaemia, acute lymphocytic leukaemia and acute myeloid leukaemia Cytobios 60(241): 103-109
Jiang, Y.Z.; Cullis, J.O.; Kanfer, E.J.; Goldman, J.M.; Barrett, A.J. 1993: T cell and NK cell mediated graft-versus-leukaemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukaemia Bone Marrow Transplantation 11(2): 133-138
Okpara, R.A.; Williams, E.E.; Schneider, J.; Wendler, I.; Hunsmann, G. 1988: HTLV-i antibodies in blood donors, patients with leukaemia, acute malaria and multiple blood transfusion recipients in the Cross River State of Nigeria East African Medical Journal 65(7): 495-502
Vassallo, R.R. 2009: Recognition and management of antibodies to human platelet antigens in platelet transfusion-refractory patients Immunohematology 25(3): 119-124
Amemiya, Y. 1997: Platelet transfusion refractoriness and effective management of platelet alloimmunization Nihon Rinsho. Japanese Journal of Clinical Medicine 55(9): 2392-2398
Holme, S.; Murphy, S. 1983: Platelet storage at 22 degrees C for transfusion: interrelationship of platelet density and size, medium pH, and viability after in vivo infusion Journal of Laboratory and Clinical Medicine 101(1): 161-174
Wöhrer, S.; Rabitsch, W.; Shehata, M.; Kondo, R.; Esterbauer, H.; Streubel, B.; Sillaber, C.; Raderer, M.; Jaeger, U.; Zielinski, C.; Valent, P. 2007: Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone Anticancer Research 27(6b): 3837-3841
Melo, J.V.; Goldman, J.M. 1992: Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia Leukemia 6(8): 786-790
Hann, I.; Vora, A.; Richards, S.; Hill, F.; Gibson, B.; Lilleyman, J.; Kinsey, S.; Mitchell, C.; Eden, O.B. 2000: Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia Leukemia 14(3): 356-363
Tsubota, T.; Miyoshi, I.; Uno, J.; Hiraki, S.; Kobayashi, T.; Sato, U.; Kimura, I. 1980: Immunological distinction of adult T cell leukaemia from T cell acute lymphoblastic leukaemia Clinical and Experimental Immunology 41(1): 130-135
Valeri, C.Robert.; Ragno, G.M. 2010: Prophylactic platelet transfusions New England Journal of Medicine 362(22): 2141; Author Reply 2141-2142
Castaigne, S. 1981: Platelet transfusion La Revue du Praticien 31(7): 519-522
Verstraete, M. 1979: Prophylactic value of platelet anti-aggregants in coronary disease La Clinica Terapeutica 91(2): 117-127
McFarland, J.G. 1996: Alloimmunization and platelet transfusion Seminars in Hematology 33(4): 315-328
Juji, T. 1978: Platelet and granulocyte transfusion and HLA Rinsho Byori. Japanese Journal of Clinical Pathology 26(10): 856-860
Brubaker, L.H.; Rosenstein, D.L. 1975: Risk and utility of platelet transfusion Missouri Medicine 72(5): 231
Rock, G.; Labow, R.S.; Adams, G.A. 1988: Storage of human platelet concentrates for transfusion Progress in Clinical and Biological Research 283: 673-704
Fu, Y.; Hu, Y.M. 1999: Prophylactic effects of tetramethyl pyrazine on mice with endotoxemia and its relationship with platelet-activating factor Zhongguo Yao Li Xue Bao 20(6): 529-532
Rosengarten, D.S.; McMichan, J.C.; Philipp, E. 1979: The effect of prophylactic proteinase inhibitor therapy on post-traumatic pulmonary insufficiency and platelet counts Advances in Experimental Medicine and Biology 120b: 349-360